该研究系统性阐释了非小细胞肺癌患者在新辅助免疫治疗联合化疗后的免疫微环境异质性，识别了患者在耐药机制方面的潜在差异，并开发了预测患者复发风险的新型生物学标志物，具有一定的基础研究与临床转化价值。

While different subtypes of T cells exist ... the molecular signals they see as they mount a defense." One type of T cell—known as a CD8—is constantly on the prowl in the human body in ...

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

LUND, SE / ACCESS Newswire / March 20, 2025 /BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

The four subtypes of carcinoma are: Serous (the most common subtype) Mucinous Endometrioid Clear Cell If the tumor cells don’t look like any of these subtypes, your carcinoma is ...